InMed Pharmaceuticals Inc expected to post a loss of $5.50 a share - Earnings Preview

InMed Pharmaceuticals

20/09/2022 13:47

* InMed Pharmaceuticals Inc  INM.OQ   INM.O  is expected
to show a
rise in quarterly revenue when it reports  results on September
23. 
    * The Vancouver British Columbia-based  company is expected
to
report revenue of $750 thousand, according to the estimate from
one analyst, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for InMed
Pharmaceuticals Inc
is for a loss of $5.50 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $20​, above​ its last closing price
of $7.80. ​​​

  
This summary was machine generated September 20 at 12:47 GMT. 
All figures in US dollars  unless otherwise stated